Sayre Therapeutics was founded in 2015 backed by leading institutional investors.

The team boasts 25 years of global executive experience in leading Pharmaceutical, Medical Diagnostics & Devices companies. Sayre Therapeutics has been identified as a high potential healthcare company, a pedigree team with proven wins and a robust clinician network in the Oncology / Immunology space. The company is uniquely positioned with a first-mover advantage, which allows for it to quickly create a portfolio of differentiated global assets in emerging markets.

Sayre is backed by two leading venture capital firms (VCs).

Our geographic footprint covers India, South Asian and South-East Asian countries which are witnessing a high growth rate across the disease areas of interest. Sayre Therapeutics with its focused strategy, strong financial backing and established relationships with clinicians and regulatory know-how, will be nimble and to that end, will prove to be a committed partner to licensors for their global assets.


We will become Asia’s specialized healthcare company of choice, providing patients and clinicians access to high-quality novel medical solutions for life-threatening diseases.


Leading the way by providing access to innovative and affordable treatment options, to improve the quality of life.


Shukrit Sudhir Chimote

Chief Executive Officer

Shukrit has a proven track record in the pharmaceutical industry and prior to founding Sayre Therapeutics, he served as Vice-President and India / South-Asia Head, Branded Formulations at Biocon, Bangalore, India. His responsibilities spanned the breadth of commercial operations including P&L management. Additionally, he headed global business development for the vertical, and directed strategies across eight business units, driving global in-licensing for them. His earlier roles at the premier Indian biotech included heading the Novel Medicines out-licensing and Biosimilars’ verticals.

Read more

Rajesh Sasidharan

Head, Finance & Administration

Rajesh comes with 13 plus years of experience across different functions in the pharmaceutical industry with deep experience in Finance and Administration. Prior to joining Sayre, he has worked with Biocon and has received awards for excellence in Oncology.

Read more